Valuation: MiniMed Group, Inc.

Market Cap 5.5B 4.76B 4.45B 4.08B 7.67B 524B 7.79B 52.17B 20.48B 263B 20.67B 20.22B 868B P/E 2027 *
29.7x
P/E 2028 * 28.8x
Enterprise Value 5.11B 4.42B 4.13B 3.79B 7.12B 487B 7.24B 48.45B 19.02B 244B 19.2B 18.78B 806B EV / Sales 2027 *
1.49x
EV / Sales 2028 * 1.33x
Free-Float
9.28%
Yield 2027 *
-
Yield 2028 * -
1 day+6.41%
1 week+8.59%
Current month+8.59%
1 month+27.52%
3 months+67.09%
1 week 18.19
Extreme 18.1866
19.76
1 month 14.7
Extreme 14.7
19.76
Current year 10.65
Extreme 10.65
20.48
1 year 10.65
Extreme 10.65
20.48
3 years 10.65
Extreme 10.65
20.48
5 years 10.65
Extreme 10.65
20.48
10 years 10.65
Extreme 10.65
20.48
Date Insider Type Main position Quantity % Market Cap.
7/31/26 Tax

Chief Executive Officer

-31,350 0.0112%
7/31/26 Tax

Chief Technology Officer

-8,012 0.0029%
7/31/26 Tax

General Counsel

-1,762 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
+6.41%+8.59% - - 5.5B
-0.06%+1.08%+34.86%+28.50% 12.79B
-0.29%-0.17%+21.63%+22.61% 6.81B
+0.79%+2.67%+57.15%+28.07% 6.21B
-0.58%-8.31%-25.19%+34.98% 4.36B
+1.30%-2.64%-22.77%-18.05% 4.04B
+4.46%+10.44%+42.40%-39.12% 1.91B
-0.51%-5.18%-15.07%+200.51% 1.75B
+3.67%+6.92%+68.57%+0.78% 1.71B
+2.97%+2.88%-28.22%-45.92% 1.3B
Average +1.82%+1.77%+14.82%+23.59% 4.64B
Weighted average by Cap. +1.25%+1.41%+21.54%+24.22%

Financials

2027 *2028 *
Net sales 3.42B 2.96B 2.76B 2.54B 4.77B 326B 4.84B 32.43B 12.73B 163B 12.85B 12.57B 540B 3.7B 3.2B 2.99B 2.74B 5.16B 352B 5.24B 35.07B 13.77B 177B 13.9B 13.59B 584B
Net income 176M 152M 142M 130M 245M 16.75B 249M 1.67B 655M 8.4B 661M 647M 27.76B 207M 179M 167M 153M 289M 19.71B 293M 1.96B 770M 9.88B 778M 761M 32.66B
Net Debt -393M -340M -317M -291M -547M -37.37B -556M -3.72B -1.46B -18.73B -1.47B -1.44B -61.92B -601M -520M -485M -445M -837M -57.17B -851M -5.69B -2.23B -28.65B -2.26B -2.21B -94.73B
Logo MiniMed Group, Inc.
MiniMed Group, Inc. is a medical technology company, which develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Its fully integrated system addresses pain points for people with diabetes (PWD): health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system. The MiniMed 780G system uses its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings. The MiniMed 780G consists of the MiniMed 780G insulin pump, the Simplera Sync CGM sensor, and the instinct sensor. Its platform of clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and a Smart Multiple Daily Injection (MDI) System. Its pipeline products are the MiniMed Flex, screenless insulin pump, next-generation Vivera dosing algorithm, and MiniMed Fit patch pump with extended wear.
Employees
-
Date Price Change Volume
26-08-07 US$19.60 +6.41% 1,629,893
26-08-06 US$18.42 -0.75% 499,796
26-08-05 US$18.56 -2.26% 1,043,498
26-08-04 US$18.99 -0.58% 1,045,013
26-08-03 US$19.10 +5.82% 921,664
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
19.60USD
Average target price
21.00USD
Spread / Average Target
+7.14%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MMED Stock